In Brief: PerSeptive Biosystems
This article was originally published in The Gray Sheet
Executive Summary
PerSeptive Biosystems: Plans to acquire its independent R&D vehicle PerSeptive Technologies II Corp. Under a definitive agreement announced Nov. 1, Biosystems will commence an offer to exchange one Biosystems share and a Biosystems share purchase warrant for each of the 2.645 mil. outstanding units of PTC-II. Formed in December 1993 ("The Gray Sheet" Nov. 22, 1993, p. 14), PTC-II contracted with Biosystems "to engage in the research and development of products in the fields of clinical diagnostics, drug screening, DNA and protein sequencing and DNA and peptide synthesis," the firm states. Biosystems now plans to begin to commercialize the technologies...